How Uncertainty Matters Under Risk Neutrality

Aug 1, 2023, 00:00
10.1016/j.jval.2023.04.008
https://www.valueinhealthjournal.com/article/S1098-3015(23)02592-5/fulltext
Title : How Uncertainty Matters Under Risk Neutrality
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02592-5&doi=10.1016/j.jval.2023.04.008
First page : 1151
Section Title : BRIEF REPORT
Open access? : Yes
Section Order : 1151

It is typical in cost-effectiveness analysis to invoke a normative decision-making framework that assumes, as a starting point, that “a quality-adjusted life-year (QALY) is a QALY is a QALY.” The implication of this assumption is that the decision maker is risk neutral and that expected values could be considered sufficiently informative for a given “approve or reject” decision. Nevertheless, it seems intuitive that less uncertainty should be desirable and this has led some to incorporate “real” risk aversion (RA) into cost-effectiveness analysis.

Categories :
  • Cost-comparison, Effectiveness, Utility, Benefit Analysis
  • Decision Modeling & Simulation
  • Economic Evaluation
  • Health Technology Assessment
  • Study Approaches
  • Value Frameworks & Dossier Format
Tags :
  • decision making
  • risk aversion
  • risk preference
  • uncertainty
Regions :
ViH Article Tags :